The Saudi Dental Journal,
Journal Year:
2024,
Volume and Issue:
36(4), P. 596 - 602
Published: Feb. 7, 2024
As
of
November
2023,
twenty-four
states,
two
territories,
and
DC
have
legalized
marijuana
for
non-medical
use,
leading
to
concerns
about
its
potential
oral
health
effects.
This
study
investigated
the
association
between
use
clinical
dental
outcomes
among
adults
in
US.
We
analyzed
data
from
National
Health
Nutrition
Examination
Survey
(NHANES)
2015
2018
using
a
cross-sectional
survey
non-institutionalized
US
civilians.
Marijuana
was
assessed
18–59-year-old
categorized
as
never,
former,
or
current
frequent
use.
The
included
prevalence
untreated
coronal
caries,
root
missing
teeth.
employed
logistic
negative
binomial
regressions
assess
crude
adjusted
associations
tooth
loss.
Of
6,424
participants,
13.85%
aged
18–59
years
were
users
(21.67
million),
with
highest
18–29-year-olds
(21.31%),
males
(17.54%),
non-Hispanic
Black
individuals
(21.31%).
Frequent
showed
caries
(33.4%).
Before
adjusting
socioeconomic
confounders,
had
1.76
times
higher
odds
having
teeth
whereas
former
1.47
odds.
However,
all
attenuated
after
tobacco
access
care.
Although
associated
worse
health,
factors,
care
more
significant
contributors
than
alone.
Substance Abuse Treatment Prevention and Policy,
Journal Year:
2023,
Volume and Issue:
18(1)
Published: June 22, 2023
Abstract
Background
In
2018,
Canada
legalized
recreational
cannabis
use
with
the
purpose
of
protecting
youth
and
restricting
access.
However,
concerns
have
been
raised
that
this
objective
has
not
met
as
rates
among
aged
16–24
declined.
Youth
is
associated
various
adverse
effects
including
psychosis,
anxiety,
depression,
suicidality,
respiratory
distress,
cannabinoid
hyperemesis
syndrome,
intoxications.
Service
providers
play
a
crucial
role
in
addressing
use.
This
study
aimed
to
understand
Ontario
service
providers’
perceptions,
practices,
recommendations
on
Methods
mixed
method
included
survey
two
focus
groups.
The
was
distributed
mental
health
serving
across
who
were
given
option
participate
group.
closed
open-ended
questions
regarding
recommendations,
while
groups
explored
these
categories
greater
depth.
Descriptive
statistics
used
analyze
close-ended
interpretative
content
analysis
applied
for
questions.
Focus
group
data
analyzed
using
thematic
analysis.
Results
completed
by
160
12
participated
Regarding
60%
participants
agreed
legalization,
26%
had
strong
understanding
medical
versus
cannabis,
84%
believed
physical
risks,
49%
perceived
stigmatization.
Less
than
half
reported
screening
or
assessing
use,
16%
stated
they
are
highly
familiar
treating
67%
rarely
work
families.
Subthemes
identified
under
perceptions
normalization
stigmatization,
harms
youth,
stigma,
racism,
discrimination.
practice
being
primary
focus,
challenges
screening,
assessment,
intervention,
referral
specialized
services.
Both
recommended
increasing
public
education,
enhancing
provider
training,
improving
regulation
policies,
reducing
stigma
minimization,
access,
providing
more
culturally
responsive
Conclusion
remains
significant
concern,
necessitating
comprehensive
plan
protect
reduce
harms.
Nicotine & Tobacco Research,
Journal Year:
2024,
Volume and Issue:
26(7), P. 940 - 947
Published: Jan. 5, 2024
We
quantified
the
linear
trend
in
combustible
tobacco
smoking
among
adolescents
United
States
from
2014
to
2020,
and
then
compared
these
trends
across
racial
ethnic
categories.
also
tested
effect
of
e-cigarette
use
on
for
all-youth
Social Psychiatry and Psychiatric Epidemiology,
Journal Year:
2023,
Volume and Issue:
58(10), P. 1457 - 1467
Published: March 13, 2023
Use
of
alcohol
and
other
substances
is
a
multifaceted
issue
impacting
young
people
across
multiple
life
domains.
This
paper
aims
to
elucidate
patterns
substance
use
associated
demographic
clinical
factors
among
seeking
treatment
for
their
mental
health.Young
(12-25
years
old)
were
recruited
from
five
youth-specific
primary
health
("headspace")
services
in
Australia.
Self-reported
harms
the
past
3
months
measured
using
WHO-ASSIST.
Network
analyses
conducted
evaluate
interrelationships
between
with
different
substances.
Subgroups
then
identified
based
on
whether
participants
reported
high
centrality
substances,
assessed
multinomial
logistic
regression.1107
youth
participated.
70%
at
least
one
months,
around
30%
those
reporting
related
health,
social,
legal
or
financial
problems.
analysis
highlighted
substantial
interconnections
harm
indicators
all
amphetamine-type
stimulants
(ATS)
cannabis
being
central
Higher
levels
subgroups
ATS
risk
these
subgroups.Findings
highlight
importance
screening
healthcare
settings,
offering
key
opportunity
early
intervention.
Clinicians
should
be
aware
inner
connections
drugs
role
amphetamine
as
marker
more
profiles.
Journal of Applied Behavior Analysis,
Journal Year:
2024,
Volume and Issue:
58(1), P. 36 - 55
Published: Aug. 28, 2024
Contingency
management
(CM),
which
involves
the
delivery
of
incentives
upon
meeting
behavioral
goals,
has
potential
to
improve
substance
use
treatment
outcomes.
The
intervention
allows
for
flexibility
through
numerous
modifiable
components
including
changes
incentive
magnitude
and
schedule,
target
behavior,
structure.
Unfortunately,
in
landscape
have
occurred
past
10
15
years:
Substances
are
more
potent,
overdose
risk
increased,
new
substances
methods
been
introduced,
classes
increasingly
being
intentionally
unintentionally
mixed.
These
developments
potentially
undermine
CM
We
explored
recent
due
legislative,
regulatory,
social,
economic
factors
four
classes:
stimulants,
opioids,
tobacco,
cannabis.
discuss
adjustments
future
research
response
these
changes.
By
continually
adapting
shifting
landscape,
can
maintain
optimal
efficacy.
International Journal of Environmental Research and Public Health,
Journal Year:
2022,
Volume and Issue:
19(21), P. 14394 - 14394
Published: Nov. 3, 2022
Given
the
rise
in
cannabis
vaping,
it
is
important
to
highlight
heterogeneity
vaping
different
product
because
of
potential
differences
their
health
risks.
This
study
aims
estimate
trends
and
socio-demographic
correlates
use
various
products
across
jurisdiction
with
legal
status.
Data
from
2018
(n
=
27,169)
2019
47,747)
waves
International
Cannabis
Policy
Study
(ICPS)
were
used.
Respondents
aged
16-65
completed
web-based
surveys.
In
2019,
proportions
past
year
oil,
dried
flower
concentrates
overall
sample
highest
U.S.
jurisdictions
where
was
legalized
for
non-medical
(17.4%,
6.0%,
4.9%),
followed
by
illegal
(13.7%,
5.8%,
2.9%),
lowest
Canada
(8.1%,
4.4%,
2.1%).
Vaping
decreased
Canada,
while
oil
increased
all
(p
<
0.001).
The
odds
forms
higher
among
younger
respondents
(16-55
years),
males,
some
college
education,
persons
low-risk
perceptions
on
daily
vaping.
both
ICPS
surveys
(2018
2019),
most
frequently
vaped
products,
flower,
concentrates.
Detailed
measures
should
be
considered
future
Campbell Systematic Reviews,
Journal Year:
2023,
Volume and Issue:
19(4)
Published: Oct. 30, 2023
Abstract
Background
Globally,
cannabis
laws
and
regulations
are
rapidly
changing.
Countries
increasingly
permitting
access
to
under
various
decriminalization,
medicalization,
legalization
laws.
With
strong
economic,
public
health,
social
justice
incentives
driving
these
domestic
policy
reforms,
liberalization
trends
bound
continue.
However,
despite
a
large
growing
body
of
interdisciplinary
research
addressing
the
policy‐relevant
safety,
socioeconomic
consequences
liberalization,
there
is
lack
robust
primary
systematic
that
comprehensively
investigates
reforms.
Objectives
This
evidence
gap
map
(EGM)
summarizes
empirical
on
policies.
Primary
objectives
were
develop
conceptual
framework
linking
policies
relevant
outcomes,
descriptively
summarize
evidence,
identify
areas
concentration
gaps.
Search
Methods
We
searched
for
eligible
English‐language
studies
published
across
23
academic
databases
11
gray
literature
sources
through
August
2020.
Additions
pool
potentially
from
supplemental
made
November
Selection
Criteria
The
this
EGM
draws
upon
legal
epidemiological
perspective
highlighting
causal
effects
law
population‐level
outcomes.
Eligible
interventions
include
create
or
expand
decriminalized
supply
cannabis:
comprehensive
medical
(MCLs),
limited
cannabidiol
(CBDLs),
recreational
(RCLs),
industrial
hemp
(IHLs),
decriminalization
cultivations
(DCLs).
outcomes
intermediate
responses
(i.e.,
attitudes/behaviors
markets/environments)
longer‐term
(health,
outcomes)
Data
Collection
Analysis
Both
dual
screening
data
extraction
performed
with
third
person
deconfliction.
appraised
using
Maryland
Scientific
Scale
reviews
assessed
AMSTAR
2.
Main
Results
includes
447
studies,
comprising
438
nine
reviews.
Most
derives
United
States,
little
other
countries.
By
far,
most
focuses
MCLs
RCLs.
Studies
targeting
laws—including
CBDLs,
IHLs,
DCLs—are
relatively
rare.
Of
113
distinct
we
documented,
use
was
single
frequently
investigated.
More
than
half
addressed
by
three
fewer
substantial
gaps
in
literature.
base
small,
just
seven
completed
(3),
opioid‐related
harms
alcohol‐related
(1).
Moreover,
have
confidence
reviews,
as
five
minimal
quality
two
low
quality.
Authors’
Conclusions
needed
better
understand
longer‐term—and
arguably
more
salient—health,
Since
concerns
RCLs,
critical
need
societal
impacts
production,
CBD
products,
cultivation.
Future
should
also
prioritize
understanding
heterogeneous
given
differences
specific
provisions
implementation
jurisdictions.